Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults.
Christina M RobertsDavid A KleinTerry A AdirimNatasha A SchveyElizabeth Hisle-GormanPublished in: The Journal of clinical endocrinology and metabolism (2022)
Our results suggest that >70% of TGD individuals who start gender-affirming hormones will continue use beyond 4 years, with higher continuation rates in transfeminine individuals. Patients who start hormones, with their parents' assistance, before age 18 years have higher continuation rates than adults.